PTEN and acute lymphoblastic leukemia: Another study that analyzed a large cohort of 573 pediatric and adult T-ALL patients treated with the GRAALL03/05 and FRALLE2000 therapeutic protocols came to the intriguing conclusion that the prognostic impact of PTEN loss is likely dependent on the underlying type of genetic anomaly [77].